Does priming implementation with low-dose albumin reduce postoperative bleeding following cardiopulmonary bypass?

International Journal of Artificial Organs

Volumn 26, Issue 3, 2003, Pages 211-216

  Onorati, F ^a   Santarpino, G ^a   Renzulli, Attilio ^a   De Feo, M ^a   De Santo, L S ^a   Della Corte, A ^a   Galdieri, N ^a   Cotrufo, M ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiopulmonary bypass; Human albumin; Postoperative bleeding; Transfusion

Indexed keywords

BLEEDINGS; CARDIOPULMONARY BYPASS; HUMAN ALBUMIN; LOW DOSE; POSTOPERATIVE BLEEDING; REOPERATION; TRANSFUSION;

ALBUMIN; ANTIDOTE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD DERIVATIVE; FENTANYL; HEPARIN; PANCURONIUM BROMIDE; PROPOFOL; PROTAMINE; RINGER LACTATE SOLUTION;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEATH; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HUMAN; HYPOTHESIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; THROMBOSIS;

EID: 0038368863     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600306     Document Type: Article

References (31)

1. High KM, Bashein G, Kurusz M. Principles of oxygenator function: Gas exchange, heat transfer, and operation. In: Gravlee GP, Davis RF, Kurusz M, eds. Cardiopulmonary Bypass, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1999; 49-68.
2. Sellke FW, Shafique T, Johnson RG, et al. Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg 1993; 55: 818-9.
3. Bunk A, Dapper F, Hata H, Neuhof H, Hehrlein FW. Experimental studies of the influence of priming solutions of complement during cardiopulmonary bypass: Comparison between the use of albumin, hydroxyethyl starch and HWA-138. J Cardiovasc Surg 1993; 34: 115-22.
4. Utley JR, Stephens DB, Wachtel C, et al. Effect of albumin and mannitol on organ blood flow, oxygen delivery, water content, and renal function during hypothermic hemodilution cardiopulmonary bypass. Ann Thorac Surg 1982; 33: 250-7.
5. Mahlon M. Wilkes, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72: 527-34.
6. Calafiore AM, Teodori G, Mezzetti A, et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59: 398-402.
7. Vander Salm TJ, Sthal RF. Early postoperative care. In: Edmunds LH, Jr ed. Cardiac Surgery in the Adult. New York: Mc Graw-Hill, 1997; pp. 339-67.
8. Boks RH, Van Herwerden, Takkenberg JM, et al. Is the use of albumin in colloid prime solution of cardiopulmonary bypass circuit justified? Ann Thorac Surg 2001; 72: 850-3.
9. Cope JT, Banks D, Mauney MC, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg 1997; 63: 78-82.
10. Brutocao D, Bratton SL, Thomas JR, Schrader PF, Coles PG, Lynn AM. Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996; 10: 348-51.
11. Knutson JE, Deering JA, Hall FW, et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000; 90: 801-7.
12. Zarro DL, Palanzo DA, Phillips TG. Albumin in the pump prime: Its effects on postoperative weight gain. Perfusion 2001; 16: 129-35.
13. Schiff P. Albumin-containing plasma volume expanders. Aust NZ J Surg 1977; 47: 783-6.
14. Sade RM, Crawford F, Dearing JP, Stround M. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1982; 84: 35-8.
15. Keyser EJ, Latter DA, Morin J, Murshid AA, Denis F, De Verennes B. Pentastarch versus albumin in cardiopulmonary bypass prime: Inpact on blood loss. J Card Surg 1999; 14: 279-86.
16. London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT. The safety and efficacy of ten percent pentastarch as a cardiopulmonary priming solution. A randomised clinical trial. J Thorac Cardiovasc Surg 1992; 104: 284-96.
17. Palanzo DA, Zarro DL, Montesano RM, Manley NJ, Albumin in the cardiopulmonary bypass prime: How little is enough? Perfusion 1999; 14: 167-72.
18. Borgdorff P, Van Der Bos G, Tangelder GJ. Extracorporeal circulation can induce hypotension by both blood-material contact and pump-induced platelet aggregation. J Thorac Cardiovasc Surg 2000; 120: 12-9.
19. Palanzo DA, Zarro DL, Manley NJ, Montesano RM, Quinn M, Gustafsons PA. Effect of surface coating on platelet count drop during cardiopulmonary bypass. Perfusion 1999; 14: 195-200.
20. Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann G. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 1992; 74: 219-25.
21. Palanzo DA, Parr GV, Bull AP, Williams DR, O'Neill MJ, Waldhausen JA. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg 1982; 34: 680-3.
22. Diehl JT, Lester JL, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982; 34: 674-9.
23. Saunders CR, Carlisle L, Bick RL. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solution. Ann Thorac Surg 1983; 36: 532-9.
24. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin forcolloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg 1984; 37: 40-6.
25. Tigehelaar I, Gallandat Huet RC, Korsten J, Boonstra PV, Van Oeveren W. Hemostatic effects on three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg 1997; 11: 626-32.
26. London MJ, Ho JS, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989; 97; 785-97.
27. Himpe D, Van Cauwelaert P, Neels H, et al. Priming solutions for cardiopulmonary bypass: Comparison of three colloids. J Cardiothorac Vasc Anesth 1991, 5: 457-66.
28. Mastroianni L, Low HB, Rollman J, Wagle M, Bleske B, Chow MS. A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. J Clin Pharmacol 1994; 34: 34-40.
29. Tigchelaar I, Gallandat Huet RC, Boonstra PW, Van Oeveren W. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion 1998; 13: 297-303.
30. Sade RM, Stroud MR, Crawford FA Jr., et al. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 89: 713-22.
31. Marelli D, Paul A, Samson R. Does the addition of albumin to the priming solution in cardiopulmonary bypass affect clinical outcome? J Thorac Cardiovasc Surg 1989; 98: 751-6.